Cerity Partners
XERS icon

Cerity Partners’s Xeris Biopharma Holdings XERS Stock Holding History

Cerity Partners’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Buy
40,999
+10,416
+34% +$66.5K ﹤0.01% 2736
2026
Q1 		$177K Buy
30,583
+1,005
+3% +$6.66K ﹤0.01% 2910
2025
Q4 		$232K Sell
29,578
-1,455
-5% -$11.5K ﹤0.01% 2550
2025
Q3 		$253K Buy
31,033
+2,905
+10% +$19.3K ﹤0.01% 2397
2025
Q2 		$131K Sell
28,128
-3,723
-12% -$17.1K ﹤0.01% 2438
2025
Q1 		$175K Buy
31,851
+16,484
+107% +$66.5K ﹤0.01% 2246
2024
Q4 		$51.3K Buy
15,367
+171
+1% +$550 ﹤0.01% 2380
2024
Q3 		$43.3K Buy
+15,196
New +$39K ﹤0.01% 2492

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cerity Partners's XERS Position: Q2 2026 in Review

Cerity Partners increased its Xeris Biopharma Holdings (XERS) stake by 34% in Q2 2026, buying an estimated $66.5K and bringing the position to 40,999 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Cerity Partners first reported a position in XERS in Q3 2024 and has held it in 8 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Cerity Partners held 40,999 shares of Xeris Biopharma Holdings worth $325K as of Q2 2026.
  • Cerity Partners bought 10,416 Xeris Biopharma Holdings shares in Q2 2026, an estimated $66.5K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2736 holding.
  • Cerity Partners first reported a position in Xeris Biopharma Holdings in Q3 2024 and has held it in 8 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.